Detected ·
201 Therapeutics
——
201 Therapeutics secured CHF 40,000 in Venture Kick Stage II funding to advance oral small molecule therapies for hepatocellular carcinoma (liver cancer).
- Website
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-27 08:04:47 UTC
- Signal ID
- 62d704af-4af5-4241-80b3-75f170326b5a
As the API returns it
{
"id": "62d704af-4af5-4241-80b3-75f170326b5a",
"created_at": "2026-05-27T08:04:47.615664Z",
"company_name": "201 Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/201-therapeutics",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*201 Therapeutics secured CHF 40,000 in Venture Kick Stage II funding to advance oral small molecule therapies for hepatocellular carcinoma (liver cancer).*"
}